Eledon Pharmaceuticals, Inc. (ELDN): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Operating Income or Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$18.46M
Year ended 2020-12-31
2016-12-31: -$5.09M2017-12-31: -$13.10M2018-12-31: -$14.05M2019-12-31: -$16.04M2020-12-31: -$18.46M-$18.46M
2016-12-31 EBITDA (USD) 2020-12-31
Period endedEBITDAChange YoYSource filing
2020-12-31-$18.46Mn/m2022-03-24, From 2020-01-01
2019-12-31-$16.04Mn/m2021-03-31, From 2019-01-01
2018-12-31-$14.05Mn/m2020-03-17, From 2018-01-01
2017-12-31-$13.10Mn/m2019-03-28, From 2017-01-01
2016-12-31-$5.09Mn/a2018-04-02, From 2016-01-01